title: Control of severe hyperparathyroidism and regression of a brown tumour after treatment with i.v. alfacalcidol in a uraemic patient.
authors.affiliation: Department of Nephrology, University Hospital Lapeyronie, Montpellier, France.
authors.forename: G
authors.initials: G
authors.lastname: Mourad
authors.forename: A
authors.initials: A
authors.lastname: Argilés
authors.forename: C
authors.initials: C
authors.lastname: Vela
authors.forename: R
authors.initials: R
authors.lastname: Lorho
authors.forename: J L
authors.initials: JL
authors.lastname: Flavier
authors.forename: B
authors.initials: B
authors.lastname: Canaud
authors.forename: C M
authors.initials: CM
authors.lastname: Mion
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000209:etiology; D007262:Infusions, Intravenous; D008439:Maxillary Diseases / Q000188:drug therapy* / Q000209:etiology; D010002:Osteitis Fibrosa Cystica / Q000188:drug therapy* / Q000209:etiology; D014511:Uremia / Q000150:complications*
chemical_list: D006887:Hydroxycholecalciferols; C008088:alfacalcidol